About Resolution Therapeutics
Resolution Therapeutics is a company based in Edinburgh (United Kingdom) founded in 2017 by John Campbell and Stuart Forbes.. Resolution Therapeutics has raised $119.88 million across 2 funding rounds from investors including Syncona. The company has 6 employees as of March 31, 2021. Resolution Therapeutics offers products and services including RTX001 and Macrophage Cell Therapies. Resolution Therapeutics operates in a competitive market with competitors including Aclaris Therapeutics, NGM Biopharmaceuticals, Escient Pharmaceuticals, Nimbus Therapeutics and Alpine Immune Sciences, among others.
- Headquarter Edinburgh, United Kingdom
- Employees 6 as on 31 Mar, 2021
- Founders John Campbell, Stuart Forbes
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Resolution Therapeutics Limited
- Date of Incorporation 14 Dec, 2017
- Jurisdiction LONDON, ENGLAND
-
Annual Revenue
-
Net Profit
$-4.95 M (USD)-254as on Mar 31, 2022
-
EBITDA
$-5.39 M (USD)-285as on Mar 31, 2022
-
Total Equity Funding
$119.88 M (USD)
in 2 rounds
-
Latest Funding Round
$84.3 M (USD), Series B
Oct 03, 2024
- Investors
-
Employee Count
6
as on Mar 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Resolution Therapeutics
Resolution Therapeutics offers a comprehensive portfolio of products and services, including RTX001 and Macrophage Cell Therapies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treats end-stage liver disease using regenerative macrophages for organ repair.
Addresses inflammatory organ damage through engineered cell-based treatments.
Unlock access to complete
Funding Insights of Resolution Therapeutics
Resolution Therapeutics has successfully raised a total of $119.88M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $84.3 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $84.3M
-
First Round
First Round
(02 Dec 2020)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2024 | Amount | Series B - Resolution Therapeutics | Valuation | Syncona |
|
| Dec, 2020 | Amount | Series A - Resolution Therapeutics | Valuation | Syncona |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Resolution Therapeutics
Resolution Therapeutics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Syncona. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare investments are managed via private equity by Syncona.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Resolution Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Resolution Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Resolution Therapeutics Comparisons
Competitors of Resolution Therapeutics
Resolution Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aclaris Therapeutics, NGM Biopharmaceuticals, Escient Pharmaceuticals, Nimbus Therapeutics and Alpine Immune Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel dermatologic therapies are developed for skin conditions.
|
|
| domain | founded_year | HQ Location |
Biologics are developed for cardio-metabolic and liver diseases.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of immunotherapies to treat cancer and autoimmune disorders
|
|
| domain | founded_year | HQ Location |
GPCR drug discovery platform is developed for multiple diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Resolution Therapeutics
Frequently Asked Questions about Resolution Therapeutics
When was Resolution Therapeutics founded?
Resolution Therapeutics was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Where is Resolution Therapeutics located?
Resolution Therapeutics is headquartered in Edinburgh, United Kingdom. It is registered at Edinburgh, Scotland, United Kingdom.
Is Resolution Therapeutics a funded company?
Resolution Therapeutics is a funded company, having raised a total of $119.88M across 2 funding rounds to date. The company's 1st funding round was a Series A of $35.58M, raised on Dec 02, 2020.
How many employees does Resolution Therapeutics have?
As of Mar 31, 2021, the latest employee count at Resolution Therapeutics is 6.
What does Resolution Therapeutics do?
Resolution Therapeutics was founded in 2017 in Edinburgh, United Kingdom, focusing on biotechnology. Cell therapies based on macrophage biology, engineering, and manufacturing processes are developed by the company. These therapies target inflammatory and liver diseases by enhancing immune responses, preventing organ damage from inflammation, aiding wound sterilization, and supporting organ repair. Operations center on proprietary platforms for therapeutic solutions in this sector.
Who are the top competitors of Resolution Therapeutics?
Resolution Therapeutics's top competitors include Escient Pharmaceuticals, Nimbus Therapeutics and Alpine Immune Sciences.
What products or services does Resolution Therapeutics offer?
Resolution Therapeutics offers RTX001 and Macrophage Cell Therapies.
Who are Resolution Therapeutics's investors?
Resolution Therapeutics has 1 investor. Key investors include Syncona.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.